Where does Andrew Perlman work?

Andrew Perlman is Managing Partner at GreatPoint Ventures and Board director at Guide Therapeutics and Board director at Biobot Analytics and Board director at OncoResponse.

What check size does Andrew Perlman write?

Andrew Perlman typically writes checks of $3M – $10M.

What companies has Andrew Perlman invested in?

Investments tracked here include GreatPoint Energy, Jetti Resources.

Where did Andrew Perlman go to school?

Andrew Perlman studied at Washington University in St. Louis.

Andrew Perlman

Investor

Managing Partner at GreatPoint Ventures · Board director at Guide Therapeutics · Board director at Biobot Analytics · Board director at OncoResponse

Nantucket, Massachusetts, United States

Writes $3M – $10M checks · typically $8M

About

Andrew Perlman dropped out at 19 and co-founded nine companies across multiple sectors, including energy and life sciences, led GreatPoint Energy’s record China fundraising and co-founded two NASDAQ-listed pharma firms.

Contact· self-published, not guessed

a•••@gpv.comreveal

Likely email· guessed from name + firm domain, not firm-published

a•••@gpv.comreveal80% confident

Invests in

AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareHealthtechNew MaterialsSemiconductors

Board director at Guide Therapeutics

Intro paths

→

In turn, Andrew can intro founders to Guide Therapeutics's investors below.

Guide Therapeutics's investors · 2

GreatPoint VenturesSan Francisco · $250K – $20M checks · since 2020 GV (Google Ventures)Mountain View · $250K – $50M checks · since 2020

Co-founders at Guide Therapeutics

James DahlmanExecutive Officer, Director

Board director at Biobot Analytics YC W18

Intro paths

Andrew went through Y Combinator (Winter 2018) — any YC alum in your network can reach them through the YC community.

→

In turn, Andrew can intro founders to Biobot Analytics's investors below.

Biobot Analytics's investors · 13

American Family Insurance Institute for Corporate and Social ImpactMadison Blindspot Ventures Management CoBoston DCVC (Data Collective)Palo Alto · $5M – $25M checks Dorm RoomBrooklyn · $90K – $250K checks GreatPoint VenturesSan Francisco · $250K – $20M checks · since 2025 HomebrewBurlingame · $100K – $500K checks Hyperplane Venture CapitalBoston · $250K – $3M checks National Institutes of Health (NIH)since 2020 Pathbreaker VenturesSan Francisco · $250K – $1M checks Plum Alley InvestmentsNew York · $500K – $1.5M checks The Engine VenturesCambridge Thursday VenturesBrandon Y CombinatorSan Francisco · $500K checks · since 2018

Co-founders at Biobot Analytics

Newsha GhaeliCofounder & President

Mariana MatusFounder

Mariana Guadalupe Matus GarciaExecutive Officer, Director

Board director at OncoResponse

Intro paths

→

In turn, Andrew can intro founders to OncoResponse's investors below.

OncoResponse's investors · 7

3B Future Health FundMonaco · $12M checks · since 2025 ARCH Venture PartnersChicago · $50K – $250M checks · since 2021 Canaan PartnersStamford · $500K – $20M checks · since 2025 GreatPoint VenturesSan Francisco · $250K – $20M checks Qatar Investment AuthorityDoha RiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2025 Yonjin Venture LLCCambridge

Experience

GreatPoint VenturesFounding Managing Partnercurrent2015 — present
Jetti ResourcesFoundercurrent2014 — present
ampCNGBoard Member2012 — 2016
GreatPoint EnergyFounder2005 — 2015
AltaRock EnergyFounder2007 — 2011
Zafgen, Inc.Founder2005 — 2010
Sirtris PharmaceuticalsFounder2004 — 2005
Coatue CorporationFounder2001 — 2004
Cignal Global CommunicationsFounder1995 — 2001

Skills & more

Public Speaking2Entrepreneurship11Social Entrepreneurship3Fundraising2Start-ups7Energy7Renewable Energy7Sustainability2Technology Transfer3Venture Capital6Start-up Ventures3Start-ups Management1

+8 more

Mergers & AcquisitionsIPOExit StrategiesPrivate EquityNatural GasMineral ExplorationOil & GasLongevity

From Andrew's professional profile.

Investments

Investor

GreatPoint EnergyJetti Resources

Per the firm's website.

Colleagues at GreatPoint Ventures

Anita Khamvongsa

Executive Assistant and Office Manager at GreatPoint Ventures

Ashley Sommerschield

COO at GreatPoint Ventures

Ashok Krishnamurthi

Managing Partner at GreatPoint Ventures

Avi Goldberg

Partner at GreatPoint Ventures

Dave Bright

Investor at GreatPoint Ventures

David Resnekov

Investor at GreatPoint Ventures

DJ Patil

General Partner at GreatPoint Ventures

Gautam Krishnamurthi

Partner at GreatPoint Ventures

Network8

Alexandre LazarowScout

Managing Partner at Fluent Ventures

DJ PatilScout

General Partner at GreatPoint Ventures

George ZacharyScout

Investor at CRV (Charles River Ventures)

Omar El-AyatScout

Managing Partner at Euclid Venture Partners

Avi Goldberg

Partner at GreatPoint Ventures

David Resnekov

Investor at GreatPoint Ventures

Mike

Venture Advisor at Ranch Ventures

Seth Teicher

Scout at GreatPoint Ventures

Investors connected to Andrew in public investor directories — a warm-intro map.

Frequently asked questions

Who is Andrew Perlman?: Andrew Perlman dropped out at 19 and co-founded nine companies across multiple sectors, including energy and life sciences, led GreatPoint Energy’s record China fundraising and co-founded two NASDAQ-listed pharma firms.
Where does Andrew Perlman work?: Andrew Perlman is Managing Partner at GreatPoint Ventures and Board director at Guide Therapeutics and Board director at Biobot Analytics and Board director at OncoResponse.
What does Andrew Perlman invest in?: Andrew Perlman invests in AI & Machine Learning, Biotech, Data & Infrastructure, Enterprise Software, Healthtech, New Materials, Semiconductors.
What check size does Andrew Perlman write?: Andrew Perlman typically writes checks of $3M – $10M.
What companies has Andrew Perlman invested in?: Investments tracked here include GreatPoint Energy, Jetti Resources.
Where did Andrew Perlman go to school?: Andrew Perlman studied at Washington University in St. Louis.